FY20 results reflect the severe impact on the company from the reductions in elective surgeries around the world. However, the business has weathered the storm and looks to be in a stronger position to capitalise when activity levels normalise, especially given pent up demand. In recent months, management has moved to position the business to benefit when this recovery comes, including taking market share by winning new accounts in the UK, completely rebuilding its routes to market in the US, st ....
